- $83.22bn
- $91.34bn
- $463.46m
- 46
- 55
- 84
- 67
Annual income statement for Strategy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 481 | 511 | 499 | 496 | 463 |
| Cost of Revenue | |||||
| Gross Profit | 390 | 419 | 396 | 386 | 334 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 494 | 1,295 | 1,775 | 567 | 2,339 |
| Operating Profit | -13.6 | -785 | -1,276 | -70.4 | -1,876 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20 | -811 | -1,322 | -125 | -1,934 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.52 | -535 | -1,470 | 429 | -1,167 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.52 | -535 | -1,470 | 429 | -1,167 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -7.52 | -535 | -1,470 | 438 | -1,167 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.397 | 0.044 | -5.6 | 2.92 | 0.061 |